StockData
Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc (BDRX) stock

BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.04−0.10 (-4.89%)

Close on Nov 18, 2026Market cap $4.60MP/E –Yield –

Biodexa Pharmaceuticals shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 54.86B, up 1007.7% from the year before. Over ten years it grew 288.2% a year on average. The highest annual figure on record is 54.86B in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202554.86B+1007.7%
FY2024Dec 31, 20244.95B+1468.1%
FY2023Dec 31, 2023316M+6291.4%
FY2022Dec 31, 20225M+22.7%
FY2021Dec 31, 20214M+88.0%
FY2020Dec 31, 20202M+133.7%
FY2019Dec 31, 20191M+499.8%
FY2018Dec 31, 20180M+19.1%
FY2017Dec 31, 20170M+42.3%
FY2016Dec 31, 20160M+27.8%
FY2015Dec 31, 20150M–

More Biodexa Pharmaceuticals figures

See a number that looks wrong?